VTv Operating Cycle from 2010 to 2024

VTVT Stock  USD 15.51  0.09  0.58%   
VTv Therapeutics Operating Cycle yearly trend continues to be comparatively stable with very little volatility. Operating Cycle will likely drop to 2,030 in 2024. From the period from 2010 to 2024, VTv Therapeutics Operating Cycle quarterly data regression had r-value of  0.15 and coefficient of variation of  184.95. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
2.7 K
Current Value
K
Quarterly Volatility
3.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
  
Check out the analysis of VTv Therapeutics Correlation against competitors.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Latest VTv Therapeutics' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of vTv Therapeutics over the last few years. It is VTv Therapeutics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Pretty Stable
   Operating Cycle   
       Timeline  

VTv Operating Cycle Regression Statistics

Arithmetic Mean1,862
Geometric Mean206.62
Coefficient Of Variation184.95
Mean Deviation2,366
Median82.27
Standard Deviation3,444
Sample Variance11.9M
Range10K
R-Value0.15
Mean Square Error12.5M
R-Squared0.02
Significance0.61
Slope111.77
Total Sum of Squares166.1M

VTv Operating Cycle History

2024 2029.52
2023 2651.0
2022 2305.22
2021 415.31
2020 21.28
2018 6.7

About VTv Therapeutics Financial Statements

VTv Therapeutics shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle2.7 KK

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.